SCHEMBL8869489

SCHEMBL8869489

CC(C)OC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(Cl)cc3)cc2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.50
EGFR P00533 1/20 0.48
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44
KDR P35968 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 3/20 0.43
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 1/20 0.43
FABP2 P12104 1/20 0.43
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869237 1.00 PPARA (0.50) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL8868754 0.93 PPARA (0.48) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8868676 0.92 MAPT (0.49) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869129 0.92 MAPT (0.49) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8868842 0.92 P4HTM (0.48) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL9140567 0.92 EGFR (0.52) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL8868677 0.92 MAPT (0.48) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869223 0.92 P4HTM (0.55) PPARARAB9AMEN1KMT2AMAPT
SCHEMBL8869066 0.91 PPARA (0.53) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL8869698 0.91 PPARA (0.53) PPARAEGFRNPC1RAB9AFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed